Role of p16 and p53 in oral potentially malignant disorders and oral squamous cell carcinoma: A study in Malaysia

Nyi Mas Siti Purwaningsih, Ahmad Tarmidi Sailan, Suraya Hani Mohd. Sinon, Ajura Abdul Jalil

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ninety-five percentages of oral cancer are classified as oral squamous cell carcinoma (OSCC). p16 and p53 are protein in human cell cycle regulation that can play role as tumour suppressor genes. The purpose of the research is to detect p16 and p53 expressions in oral potentially malignant disorders (OPMDs) and OSCC using immunohistochemistry (IHC). A total of 87 formalin-fixed paraffin embedded tissue were selected comprising of OPMDs cases (n=32), OSCC cases (n=46) and normal oral mucosa (n=9). The cases were retrieved from the archives of the Oral Pathology Laboratory, Faculty of Dentistry, UKM, Institute of Medical Research and Hospital Tunku Mizan. The IHC staining was manually performed using p16 antibody (1:1000) (Abcam) and p53 antibody (clone DO-7,Dako, Denmark) following manufacturer's instruction and assessed semi-quantitatively (positivity and staining intensity) between all groups. Positive and negative controls were used to validate the IHC run. All data were then analysed using SPSS version 22.0 and p values < 0.05 were considered significant. The p16 were found positive in OSCC (96.7%) and in OPMDs (84.38%). There is significantly higher p16 positivity in OSCC compared to normal oral mucosa (p < 0.001). The p53 expression was detected in OPMDs and OSCC. There are significant differences between p53 expression among in NOM and OSCC (p < 0.01) as well as OPMDs and OSCC (p < 0.05). In this present study, p16 and p53 expressions were increased following degree of malignancy. The finding suggests that p16 and p53 can be used as a potential marker for oral malignancy detection.

Original languageEnglish
Pages (from-to)42-47
Number of pages6
JournalJournal of International Dental and Medical Research
Volume10
Issue number1
Publication statusPublished - 2017

Fingerprint

Malaysia
Squamous Cell Carcinoma
Immunohistochemistry
Mouth Mucosa
Oral Pathology
Staining and Labeling
Antibodies
Mouth Neoplasms
Denmark
Dentistry
Tumor Suppressor Genes
Paraffin
Formaldehyde
Biomedical Research
Neoplasms
Cell Cycle
Clone Cells
Research

Keywords

  • OPMDs
  • OSCC
  • P16
  • P53

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Role of p16 and p53 in oral potentially malignant disorders and oral squamous cell carcinoma : A study in Malaysia. / Purwaningsih, Nyi Mas Siti; Sailan, Ahmad Tarmidi; Mohd. Sinon, Suraya Hani; Jalil, Ajura Abdul.

In: Journal of International Dental and Medical Research, Vol. 10, No. 1, 2017, p. 42-47.

Research output: Contribution to journalArticle

@article{673d603a1d804b25a3a49b4a0303d6ee,
title = "Role of p16 and p53 in oral potentially malignant disorders and oral squamous cell carcinoma: A study in Malaysia",
abstract = "Ninety-five percentages of oral cancer are classified as oral squamous cell carcinoma (OSCC). p16 and p53 are protein in human cell cycle regulation that can play role as tumour suppressor genes. The purpose of the research is to detect p16 and p53 expressions in oral potentially malignant disorders (OPMDs) and OSCC using immunohistochemistry (IHC). A total of 87 formalin-fixed paraffin embedded tissue were selected comprising of OPMDs cases (n=32), OSCC cases (n=46) and normal oral mucosa (n=9). The cases were retrieved from the archives of the Oral Pathology Laboratory, Faculty of Dentistry, UKM, Institute of Medical Research and Hospital Tunku Mizan. The IHC staining was manually performed using p16 antibody (1:1000) (Abcam) and p53 antibody (clone DO-7,Dako, Denmark) following manufacturer's instruction and assessed semi-quantitatively (positivity and staining intensity) between all groups. Positive and negative controls were used to validate the IHC run. All data were then analysed using SPSS version 22.0 and p values < 0.05 were considered significant. The p16 were found positive in OSCC (96.7{\%}) and in OPMDs (84.38{\%}). There is significantly higher p16 positivity in OSCC compared to normal oral mucosa (p < 0.001). The p53 expression was detected in OPMDs and OSCC. There are significant differences between p53 expression among in NOM and OSCC (p < 0.01) as well as OPMDs and OSCC (p < 0.05). In this present study, p16 and p53 expressions were increased following degree of malignancy. The finding suggests that p16 and p53 can be used as a potential marker for oral malignancy detection.",
keywords = "OPMDs, OSCC, P16, P53",
author = "Purwaningsih, {Nyi Mas Siti} and Sailan, {Ahmad Tarmidi} and {Mohd. Sinon}, {Suraya Hani} and Jalil, {Ajura Abdul}",
year = "2017",
language = "English",
volume = "10",
pages = "42--47",
journal = "Journal of International Dental and Medical Research",
issn = "1309-100X",
publisher = "Ektodermal Displazi Grubu",
number = "1",

}

TY - JOUR

T1 - Role of p16 and p53 in oral potentially malignant disorders and oral squamous cell carcinoma

T2 - A study in Malaysia

AU - Purwaningsih, Nyi Mas Siti

AU - Sailan, Ahmad Tarmidi

AU - Mohd. Sinon, Suraya Hani

AU - Jalil, Ajura Abdul

PY - 2017

Y1 - 2017

N2 - Ninety-five percentages of oral cancer are classified as oral squamous cell carcinoma (OSCC). p16 and p53 are protein in human cell cycle regulation that can play role as tumour suppressor genes. The purpose of the research is to detect p16 and p53 expressions in oral potentially malignant disorders (OPMDs) and OSCC using immunohistochemistry (IHC). A total of 87 formalin-fixed paraffin embedded tissue were selected comprising of OPMDs cases (n=32), OSCC cases (n=46) and normal oral mucosa (n=9). The cases were retrieved from the archives of the Oral Pathology Laboratory, Faculty of Dentistry, UKM, Institute of Medical Research and Hospital Tunku Mizan. The IHC staining was manually performed using p16 antibody (1:1000) (Abcam) and p53 antibody (clone DO-7,Dako, Denmark) following manufacturer's instruction and assessed semi-quantitatively (positivity and staining intensity) between all groups. Positive and negative controls were used to validate the IHC run. All data were then analysed using SPSS version 22.0 and p values < 0.05 were considered significant. The p16 were found positive in OSCC (96.7%) and in OPMDs (84.38%). There is significantly higher p16 positivity in OSCC compared to normal oral mucosa (p < 0.001). The p53 expression was detected in OPMDs and OSCC. There are significant differences between p53 expression among in NOM and OSCC (p < 0.01) as well as OPMDs and OSCC (p < 0.05). In this present study, p16 and p53 expressions were increased following degree of malignancy. The finding suggests that p16 and p53 can be used as a potential marker for oral malignancy detection.

AB - Ninety-five percentages of oral cancer are classified as oral squamous cell carcinoma (OSCC). p16 and p53 are protein in human cell cycle regulation that can play role as tumour suppressor genes. The purpose of the research is to detect p16 and p53 expressions in oral potentially malignant disorders (OPMDs) and OSCC using immunohistochemistry (IHC). A total of 87 formalin-fixed paraffin embedded tissue were selected comprising of OPMDs cases (n=32), OSCC cases (n=46) and normal oral mucosa (n=9). The cases were retrieved from the archives of the Oral Pathology Laboratory, Faculty of Dentistry, UKM, Institute of Medical Research and Hospital Tunku Mizan. The IHC staining was manually performed using p16 antibody (1:1000) (Abcam) and p53 antibody (clone DO-7,Dako, Denmark) following manufacturer's instruction and assessed semi-quantitatively (positivity and staining intensity) between all groups. Positive and negative controls were used to validate the IHC run. All data were then analysed using SPSS version 22.0 and p values < 0.05 were considered significant. The p16 were found positive in OSCC (96.7%) and in OPMDs (84.38%). There is significantly higher p16 positivity in OSCC compared to normal oral mucosa (p < 0.001). The p53 expression was detected in OPMDs and OSCC. There are significant differences between p53 expression among in NOM and OSCC (p < 0.01) as well as OPMDs and OSCC (p < 0.05). In this present study, p16 and p53 expressions were increased following degree of malignancy. The finding suggests that p16 and p53 can be used as a potential marker for oral malignancy detection.

KW - OPMDs

KW - OSCC

KW - P16

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=85018745725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018745725&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85018745725

VL - 10

SP - 42

EP - 47

JO - Journal of International Dental and Medical Research

JF - Journal of International Dental and Medical Research

SN - 1309-100X

IS - 1

ER -